Fetal major cardiac defects and placental dysfunction at 11–13 weeks' gestation

By  

ULTRASOUND IN OBSTETRICS & GYNECOLOGY, Vol. 51, Iss. 2, 2018-02 ,pp. : 194-198

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetic/pharmacodynamic modelling of cardiac toxicity in venlafaxine overdose

By Mégarbane Bruno   Bloch Vanessa   Deye Nicolas   Baud Frédéric  

Intensive Care Medicine, Vol. 33, Iss. 1, 2007-01 ,pp. : 195-196

Springer Publishing Company

Access to resources Recommend Favorite

Assessment of Canadian provincial expenditures in depressed patients treated with venlafaxine XR versus SSRIs: the APEX Study

By Monfared A. A. Tahami   Han D.   Sheehy O.   Bexton B.   LeLorier J.  

Current Medical Research and Opinion, Vol. 22, Iss. 1, 2006-01 ,pp. : 83-94

Informa Healthcare

Access to resources Recommend Favorite

Healthcare expenditure in severely depressed patients treated with escitalopram, generic SSRIs or venlafaxine in the UK

By Wade Alan G.   Saragoussi Delphine   Despiégel Nicolas   François Clément   Guelfucci Florent   Toumi Mondher  

Current Medical Research and Opinion, Vol. 26, Iss. 5, 2010-05 ,pp. : 1161-1170

Informa Healthcare

Access to resources Recommend Favorite

Maternal hypertensive disorders, antihypertensive medication use, and the risk of birth defects: a case–control study

By  

BJOG : AN INTERNATIONAL JOURNAL OF OBSTETRICS & GYNAECOLOGY, Vol. 122, Iss. 7, 2015-06 ,pp. : 1002-1009

John Wiley & Sons Inc

Access to resources Recommend Favorite